Cognitive complaint in early Parkinson's disease: A pilot study
J Dupouy1,2, F Ory-Magne1,2,3, C Mekies4
1Department of Neurology, University Hospital of Toulouse, Toulouse, France.
Acta Neurologica Scandinavica
|August 24, 2017
Summary
Subjective cognitive complaints (SCC) appear early in Parkinson's disease (PD), particularly in executive functions, language, and attention. A visual analogue scale (VAS) shows promise for detecting these early cognitive changes in PD patients.
Area of Science:
- Neurology
- Neuropsychology
- Cognitive Science
Background:
- Subjective cognitive complaint (SCC) is crucial for diagnosing mild cognitive impairment (MCI) per Movement Disorder Society (MDS) guidelines.
- Limited tools exist for assessing SCC specifically in Parkinson's disease (PD).
- This study aimed to develop and evaluate a novel tool for SCC detection in PD.
Purpose of the Study:
- To develop an easy-to-use visual analogue scale (VAS) for assessing subjective cognitive complaints (SCC) in Parkinson's disease (PD).
- To evaluate the comprehensibility, reproducibility, and validity of the VAS tool in PD patients.
Main Methods:
- An expert panel developed a VAS tool covering memory, executive functions, spatial orientation, attention, and language.
- The VAS was administered twice, one month apart, to 70 PD patients with <5 years disease duration and to controls.
- Patients with PD also underwent standard neuropsychological testing.
Main Results:
- The VAS tool was easily understood by PD patients.
- Significant SCC were found in PD patients compared to controls in executive functions, language, and attention.
- The tool demonstrated good reproducibility, but SCC did not correlate with neuropsychological test results.
Conclusions:
- Subjective cognitive complaints (SCC) emerge early in Parkinson's disease (PD), affecting executive functions, language, and attention.
- The visual analogue scale (VAS) shows potential for detecting early SCC in PD.
- Further validation of the VAS tool is recommended.
Related Concept Videos
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
Negative and Cognitive Symptoms of Schizophrenia
748
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
748


